亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study

医学 内科学 胰腺癌 辅助化疗 肿瘤科 胰腺 回顾性队列研究 佐剂 队列 化疗 腺癌 胰腺导管腺癌 癌症 乳腺癌
作者
Ning Pu,Wenchuan Wu,Siyao Liu,Yuqi Xie,Hanlin Yin,Qiangda Chen,Tao-Chen He,Zhi-Hang Xu,Wenquan Wang,Jun Yu,Liang Liu,Wenhui Lou
出处
期刊:International Journal of Surgery [Wolters Kluwer]
被引量:5
标识
DOI:10.1097/js9.0000000000000589
摘要

Background: Patients with pancreatic ductal adenocarcinoma (PDAC) are increasingly receiving systemic neoadjuvant chemotherapy (NAC), particularly those with borderline resectable and locally advanced disease. However, the specific role of additional adjuvant chemotherapy (AC) in these patients is unknown. The objective of this study is to further assess the clinical benefit and impact of systemic AC in patients with resected PDAC after NAC. Methods: Data on PDAC patients with or without AC following systemic NAC and surgical resection were retrospectively retrieved from the Surveillance, Epidemiology, and End Results (SEER) database between 2006 and 2019. A matched cohort was created using propensity score matching (PSM), and baseline characteristics were balanced to reduce bias. Overall survival (OS) and cancer-specific survival (CSS) were calculated using matching cohorts. Results: The study enrolled a total of 1,589 patients, with 623 (39.2%) in the AC group and 966 (51.8%) in the non-AC group (mean age, 64.0 [9.9] years; 766 [48.2%] were females and 823 [51.8%] were males). All patients received NAC, and among the crude population, 582 (36.6%) received neoadjuvant radiotherapy, while 168 (10.6%) received adjuvant radiotherapy. Following the 1:1 PSM, 597 patients from each group were evaluated further. The AC and non-AC groups had significantly different median OS (30.0 vs. 25.0 mo, P =0.002) and CSS (33.0 vs. 27.0 mo, P =0.004). After multivariate Cox regression analysis, systemic AC was independently associated with improved survival ( P =0.003, HR=0.782; 95%CI, 0.667-0.917 for OS; P =0.004, HR=0.784; 95%CI, 0.663-0.926 for CSS), and age, tumor grade, and AJCC N staging were also independent predictors of survival. Only patients younger than 65 years old and those with a pathological N1 category showed a significant association between systemic AC and improved survival in the subgroup analysis adjusted for these covariates. Conclusion: Systemic AC provides a significant survival benefit in patients with resected PDAC following NAC compared to non-AC patients. Our study discovered that younger patients, patients with aggressive tumors and potentially well response to NAC might benefit from AC to achieve prolonged survival after curative tumor resection.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
俏皮的灵完成签到,获得积分10
2秒前
家俊完成签到,获得积分10
3秒前
kk完成签到,获得积分10
5秒前
5秒前
科研通AI6.2的应助被AA采纳,获得10
5秒前
田様的应助被kk采纳,获得10
8秒前
9秒前
9秒前
齐7发布了新的文献求助10
10秒前
spark完成签到,获得积分10
11秒前
chuchu完成签到 ,获得积分10
11秒前
13秒前
14秒前
包语梦发布了新的文献求助10
15秒前
15秒前
齐7完成签到,获得积分10
15秒前
涂豆泥发布了新的文献求助10
20秒前
光亮的成败完成签到,获得积分10
22秒前
傻傻的芷巧完成签到,获得积分10
24秒前
24秒前
28秒前
Yaon-Xu发布了新的文献求助10
29秒前
33秒前
祎辰完成签到 ,获得积分10
36秒前
刘甜甜完成签到,获得积分10
37秒前
顺心鼠标完成签到,获得积分10
39秒前
42秒前
Yaon-Xu发布了新的文献求助10
42秒前
NexusExplorer的应助被李密采纳,获得10
44秒前
庾傀斗发布了新的文献求助10
53秒前
李健的小迷弟的应助被医生采纳,获得10
54秒前
56秒前
58秒前
庾傀斗发布了新的文献求助10
58秒前
Rita发布了新的文献求助10
59秒前
知白发布了新的文献求助10
1分钟前
刻苦的若云完成签到 ,获得积分10
1分钟前
快乐的文博完成签到,获得积分10
1分钟前
1分钟前
庾傀斗发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172940
求助须知:如何正确求助?哪些是违规求助? 9565447
关于积分的说明 21779943
捐赠科研通 7764803
什么是DOI,文献DOI怎么找? 3431480
关于科研通互助平台的介绍 2555495
邀请新用户注册赠送积分活动 2476544